Carregant...
The combination of checkpoint immunotherapy and targeted therapy in cancer
The therapeutic possibilities for patients with metastatic melanoma have changed due to the development of targeted therapies that inhibit oncogenic signaling pathways as well as immune modulating therapies that unleash the patient antitumor immunity. These therapeutic changes have impressively incr...
Guardat en:
| Publicat a: | Ann Transl Med |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
AME Publishing Company
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5653508/ https://ncbi.nlm.nih.gov/pubmed/29114546 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2017.06.47 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|